Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 14 entries
Sorted by: Best Match Show Resources per page
TRANSPLANTATION OF WHOLE HUMAN ORGANS.

Proceedings of the American Philosophical Society

Starzl TE.
PMID: 23258937
Proc Am Philos Soc. 1971 Aug 20;115(4):258-266.

No abstract available.

Cite
Starzl TE. TRANSPLANTATION OF WHOLE HUMAN ORGANS. Proc Am Philos Soc. 1971;115(4):258-266
Starzl, T. E. (1971). TRANSPLANTATION OF WHOLE HUMAN ORGANS. Proceedings of the American Philosophical Society, 115(4), 258-266.
Starzl, Thomas E. "TRANSPLANTATION OF WHOLE HUMAN ORGANS." Proceedings of the American Philosophical Society vol. 115,4 (1971): 258-266.
Starzl TE. TRANSPLANTATION OF WHOLE HUMAN ORGANS. Proc Am Philos Soc. 1971 Aug 20;115(4):258-266. PMID: 23258937; PMCID: PMC3524985.
Copy Download .nbib Format: NLM
PCSK9 Is Increased in Youth With Type 1 Diabetes.

Diabetes care

Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB.
PMID: 28588146
Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563. Epub 2017 Jun 06.

No abstract available.

Cite
Levenson AE, Wadwa RP, Shah AS, et al. PCSK9 Is Increased in Youth With Type 1 Diabetes. Diabetes Care. 2017;40(7):e85-e87doi: 10.2337/dc16-2563.
Levenson, A. E., Wadwa, R. P., Shah, A. S., Khoury, P. R., Kimball, T. R., Urbina, E. M., de Ferranti, S. D., Bishop, F. K., Maahs, D. M., Dolan, L. M., & Biddinger, S. B. (2017). PCSK9 Is Increased in Youth With Type 1 Diabetes. Diabetes care, 40(7), e85-e87. https://doi.org/10.2337/dc16-2563
Levenson, Amy E, et al. "PCSK9 Is Increased in Youth With Type 1 Diabetes." Diabetes care vol. 40,7 (2017): e85-e87. doi: https://doi.org/10.2337/dc16-2563
Levenson AE, Wadwa RP, Shah AS, Khoury PR, Kimball TR, Urbina EM, de Ferranti SD, Bishop FK, Maahs DM, Dolan LM, Biddinger SB. PCSK9 Is Increased in Youth With Type 1 Diabetes. Diabetes Care. 2017 Jul;40(7):e85-e87. doi: 10.2337/dc16-2563. Epub 2017 Jun 06. PMID: 28588146; PMCID: PMC5481981.
Copy Download .nbib Format: NLM
High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss.

The Journal of thoracic and cardiovascular surgery

Schäfer M, Di Maria MV, Jaggers J, Stone ML, Ivy DD, Barker AJ, Mitchell MB.
PMID: 33653609
J Thorac Cardiovasc Surg. 2021 Dec;162(6):1791-1804. doi: 10.1016/j.jtcvs.2021.01.111. Epub 2021 Feb 04.

OBJECTIVE: The Norwood neoaortic arch biomechanical properties are abnormal due to reduced vessel wall compliance and abnormal geometry. Others have previously described neoaortic geometric distortion by the degree of diameter reduction (tapering) and associated this with mismatched ventricular-neoaortic coupling,...

Cite
Schäfer M, Di Maria MV, Jaggers J, et al. High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss. J Thorac Cardiovasc Surg. 2021;162(6):1791-1804doi: 10.1016/j.jtcvs.2021.01.111.
Schäfer, M., Di Maria, M. V., Jaggers, J., Stone, M. L., Ivy, D. D., Barker, A. J., & Mitchell, M. B. (2021). High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss. The Journal of thoracic and cardiovascular surgery, 162(6), 1791-1804. https://doi.org/10.1016/j.jtcvs.2021.01.111
Schäfer, Michal, et al. "High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss." The Journal of thoracic and cardiovascular surgery vol. 162,6 (2021): 1791-1804. doi: https://doi.org/10.1016/j.jtcvs.2021.01.111
Schäfer M, Di Maria MV, Jaggers J, Stone ML, Ivy DD, Barker AJ, Mitchell MB. High-degree Norwood neoaortic tapering is associated with abnormal flow conduction and elevated flow-mediated energy loss. J Thorac Cardiovasc Surg. 2021 Dec;162(6):1791-1804. doi: 10.1016/j.jtcvs.2021.01.111. Epub 2021 Feb 04. PMID: 33653609.
Copy Download .nbib Format: NLM
Pediatric Cardiology: From Basics to Innovation.

Pediatric clinics of North America

Jone PN, Ivy DD, Daniels SR.
PMID: 32888696
Pediatr Clin North Am. 2020 Oct;67(5):xvii-xviii. doi: 10.1016/j.pcl.2020.07.009. Epub 2020 Aug 10.

No abstract available.

Cite
Jone PN, Ivy DD, Daniels SR. Pediatric Cardiology: From Basics to Innovation. Pediatr Clin North Am. 2020;67(5):xvii-xviiidoi: 10.1016/j.pcl.2020.07.009.
Jone, P. N., Ivy, D. D., & Daniels, S. R. (2020). Pediatric Cardiology: From Basics to Innovation. Pediatric clinics of North America, 67(5), xvii-xviii. https://doi.org/10.1016/j.pcl.2020.07.009
Jone, Pei-Ni, et al. "Pediatric Cardiology: From Basics to Innovation." Pediatric clinics of North America vol. 67,5 (2020): xvii-xviii. doi: https://doi.org/10.1016/j.pcl.2020.07.009
Jone PN, Ivy DD, Daniels SR. Pediatric Cardiology: From Basics to Innovation. Pediatr Clin North Am. 2020 Oct;67(5):xvii-xviii. doi: 10.1016/j.pcl.2020.07.009. Epub 2020 Aug 10. PMID: 32888696.
Copy Download .nbib Format: NLM
Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury.

Journal of pulmonary & respiratory medicine

Maloney JP, Ambruso DR, Voelkel NF, Silliman CC.
PMID: 25705568
J Pulm Respir Med. 2014;4. doi: 10.4172/2161-105X.1000212.

OBJECTIVE: The occurrence of non-hemolytic transfusion reactions is highest with platelet and plasma administration. Some of these reactions are characterized by endothelial leak, especially transfusion related acute lung injury (TRALI). Elevated concentrations of inflammatory mediators secreted by contaminating leukocytes...

Cite
Maloney JP, Ambruso DR, Voelkel NF, et al. Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury. J Pulm Respir Med. 2014;4doi: 10.4172/2161-105X.1000212.
Maloney, J. P., Ambruso, D. R., Voelkel, N. F., & Silliman, C. C. (2014). Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury. Journal of pulmonary & respiratory medicine, 4. https://doi.org/10.4172/2161-105X.1000212
Maloney, James P, et al. "Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury." Journal of pulmonary & respiratory medicine vol. 4 (2014). doi: https://doi.org/10.4172/2161-105X.1000212
Maloney JP, Ambruso DR, Voelkel NF, Silliman CC. Platelet Vascular Endothelial Growth Factor is a Potential Mediator of Transfusion-Related Acute Lung Injury. J Pulm Respir Med. 2014;4. doi: 10.4172/2161-105X.1000212. PMID: 25705568; PMCID: PMC4335657.
Copy Download .nbib Format: NLM
Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes.

International journal of pediatric endocrinology

Brown TL, Maahs DM, Bishop FK, Snell-Bergeon JK, Wadwa RP.
PMID: 27099615
Int J Pediatr Endocrinol. 2016;2016:8. doi: 10.1186/s13633-016-0026-6. Epub 2016 Apr 19.

BACKGROUND: Women with type 1 diabetes (T1D) have a four-fold increased risk for cardiovascular disease (CVD) compared to non-diabetic (non-DM) women, as opposed to double the risk in T1D men compared to non-DM men. It is unclear how early...

Cite
Brown TL, Maahs DM, Bishop FK, et al. Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes. Int J Pediatr Endocrinol. 2016;2016:8doi: 10.1186/s13633-016-0026-6.
Brown, T. L., Maahs, D. M., Bishop, F. K., Snell-Bergeon, J. K., & Wadwa, R. P. (2016). Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes. International journal of pediatric endocrinology, 20168. https://doi.org/10.1186/s13633-016-0026-6
Brown, Talia L, et al. "Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes." International journal of pediatric endocrinology vol. 2016 (2016): 8. doi: https://doi.org/10.1186/s13633-016-0026-6
Brown TL, Maahs DM, Bishop FK, Snell-Bergeon JK, Wadwa RP. Influences of gender on cardiovascular disease risk factors in adolescents with and without type 1 diabetes. Int J Pediatr Endocrinol. 2016;2016:8. doi: 10.1186/s13633-016-0026-6. Epub 2016 Apr 19. PMID: 27099615; PMCID: PMC4837565.
Copy Download .nbib Format: NLM
Diabetes research in children network:availability of protocol data sets.

Journal of diabetes science and technology

Ruedy KJ, Beck RW, Xing D, Kollman C.
PMID: 18490965
J Diabetes Sci Technol. 2007 Sep;1(5):738-45. doi: 10.1177/193229680700100519.

The Diabetes Research in Children Network (DirecNet) was established in 2001 by the National Institute of Child Health and Human Development and the National Institute of Diabetes and Digestive and Kidney Diseases through special congressional funding for type 1...

Cite
Ruedy KJ, Beck RW, Xing D, et al. Diabetes research in children network:availability of protocol data sets. J Diabetes Sci Technol. 2007;1(5):738-45doi: 10.1177/193229680700100519.
Ruedy, K. J., Beck, R. W., Xing, D., & Kollman, C. (2007). Diabetes research in children network:availability of protocol data sets. Journal of diabetes science and technology, 1(5), 738-45. https://doi.org/10.1177/193229680700100519
Ruedy, Katrina J, et al. "Diabetes research in children network:availability of protocol data sets." Journal of diabetes science and technology vol. 1,5 (2007): 738-45. doi: https://doi.org/10.1177/193229680700100519
Ruedy KJ, Beck RW, Xing D, Kollman C. Diabetes research in children network:availability of protocol data sets. J Diabetes Sci Technol. 2007 Sep;1(5):738-45. doi: 10.1177/193229680700100519. PMID: 18490965; PMCID: PMC2387002.
Copy Download .nbib Format: NLM
Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers.

Pulmonary circulation

Nawaytou H, Fineman JR, Moledina S, Ivy D, Abman SH, Cerro MJD.
PMID: 33623667
Pulm Circ. 2021 Feb 09;11(1):2045894021991446. doi: 10.1177/2045894021991446. eCollection 2021.

Development of pulmonary hypertension (PH) in patients with left side heart disease (LHD) is a predictor of poor prognosis. The use of pulmonary vasodilators in PH associated with LHD (PH-LHD) is controversial. In this study, we describe the practice...

Cite
Nawaytou H, Fineman JR, Moledina S, et al. Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers. Pulm Circ. 2021;11(1):2045894021991446doi: 10.1177/2045894021991446.
Nawaytou, H., Fineman, J. R., Moledina, S., Ivy, D., Abman, S. H., & Cerro, M. J. D. (2021). Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers. Pulmonary circulation, 11(1), 2045894021991446. https://doi.org/10.1177/2045894021991446
Nawaytou, Hythem, et al. "Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers." Pulmonary circulation vol. 11,1 (2021): 2045894021991446. doi: https://doi.org/10.1177/2045894021991446
Nawaytou H, Fineman JR, Moledina S, Ivy D, Abman SH, Cerro MJD. Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers. Pulm Circ. 2021 Feb 09;11(1):2045894021991446. doi: 10.1177/2045894021991446. eCollection 2021. PMID: 33623667; PMCID: PMC7879002.
Copy Download .nbib Format: NLM
Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial.

Transplantation proceedings

Klintmalm GB, Starzl TE, Iwatsuki S, Hakala T.
PMID: 21151754
Transplant Proc. 1982 Mar;14(1):98-99.

No abstract available.

Cite
Klintmalm GB, Starzl TE, Iwatsuki S, et al. Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplant Proc. 1982;14(1):98-99
Klintmalm, G. B., Starzl, T. E., Iwatsuki, S., & Hakala, T. (1982). Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplantation proceedings, 14(1), 98-99.
Klintmalm, G B G, et al. "Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial." Transplantation proceedings vol. 14,1 (1982): 98-99.
Klintmalm GB, Starzl TE, Iwatsuki S, Hakala T. Cyclosporin A and Kidney Transplantation: Present Status of a Partially Randomized Trial. Transplant Proc. 1982 Mar;14(1):98-99. PMID: 21151754; PMCID: PMC3000229.
Copy Download .nbib Format: NLM
Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study.

Nutrition & diabetes

Barnes TL, Crandell JL, Bell RA, Mayer-Davis EJ, Dabelea D, Liese AD.
PMID: 24126768
Nutr Diabetes. 2013 Oct 14;3:e91. doi: 10.1038/nutd.2013.32.

Youth with diabetes are at an increased risk of cardiovascular disease (CVD). Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet has been shown to improve CVD risk. In this study, we evaluated whether changes in diet quality...

Cite
Barnes TL, Crandell JL, Bell RA, et al. Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study. Nutr Diabetes. 2013;3:e91doi: 10.1038/nutd.2013.32.
Barnes, T. L., Crandell, J. L., Bell, R. A., Mayer-Davis, E. J., Dabelea, D., & Liese, A. D. (2013). Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study. Nutrition & diabetes, 3e91. https://doi.org/10.1038/nutd.2013.32
Barnes, T L, et al. "Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study." Nutrition & diabetes vol. 3 (2013): e91. doi: https://doi.org/10.1038/nutd.2013.32
Barnes TL, Crandell JL, Bell RA, Mayer-Davis EJ, Dabelea D, Liese AD. Change in DASH diet score and cardiovascular risk factors in youth with type 1 and type 2 diabetes mellitus: The SEARCH for Diabetes in Youth Study. Nutr Diabetes. 2013 Oct 14;3:e91. doi: 10.1038/nutd.2013.32. PMID: 24126768; PMCID: PMC3817346.
Copy Download .nbib Format: NLM
Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women.

Journal of AIDS & clinical research

Weinberg A, Allshouse A, Kinzie K, Cho A, Davies JK, Mc Farland EJ.
PMID: 26236558
J AIDS Clin Res. 2015 Jun;6(6). doi: 10.4172/2155-6113.1000464.

OBJECTIVES: Intra-hepatic cholestasis of pregnancy (ICP) is uncommon, but has severe effects on pregnancy outcomes. ICP is characterized by elevated serum bile acids and liver enzymes and preferentially affects women with liver disorders. We compared bile acids and pregnancy...

Cite
Weinberg A, Allshouse A, Kinzie K, et al. Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women. J AIDS Clin Res. 2015;6(6)doi: 10.4172/2155-6113.1000464.
Weinberg, A., Allshouse, A., Kinzie, K., Cho, A., Davies, J. K., & Mc Farland, E. J. (2015). Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women. Journal of AIDS & clinical research, 6(6), . https://doi.org/10.4172/2155-6113.1000464
Weinberg, Adriana, et al. "Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women." Journal of AIDS & clinical research vol. 6,6 (2015). doi: https://doi.org/10.4172/2155-6113.1000464
Weinberg A, Allshouse A, Kinzie K, Cho A, Davies JK, Mc Farland EJ. Intrahepatic Cholestasis of Pregnancy and Serum Bile Acids in HIV-Infected Pregnant Women. J AIDS Clin Res. 2015 Jun;6(6). doi: 10.4172/2155-6113.1000464. PMID: 26236558; PMCID: PMC4519986.
Copy Download .nbib Format: NLM
Effects of comorbid conditions on health-related quality of life in youth with Type 2 diabetes: the TODAY clinical trial.

Diabetes management (London, England)

Larkin ME, Walders-Abramson N, Hirst K, Keady J, Ievers-Landis CE, Venditti EM, Yasuda PM.
PMID: 27057209
Diabetes Manag (Lond). 2015 Nov;5(6):431-439. doi: 10.2217/dmt.15.35.

AIM: To explore associations between health-related quality of life (HRQOL) and comorbidities in youth with Type 2 diabetes.PATIENTS & METHODS: Of 699 youth in the TODAY study, 685 (98%) had baseline HRQOL data, 649 (93%) at 6 months and...

Cite
Larkin ME, Walders-Abramson N, Hirst K, et al. Effects of comorbid conditions on health-related quality of life in youth with Type 2 diabetes: the TODAY clinical trial. Diabetes Manag (Lond). 2015;5(6):431-439doi: 10.2217/dmt.15.35.
Larkin, M. E., Walders-Abramson, N., Hirst, K., Keady, J., Ievers-Landis, C. E., Venditti, E. M., & Yasuda, P. M. (2015). Effects of comorbid conditions on health-related quality of life in youth with Type 2 diabetes: the TODAY clinical trial. Diabetes management (London, England), 5(6), 431-439. https://doi.org/10.2217/dmt.15.35
Larkin, Mary E, et al. "Effects of comorbid conditions on health-related quality of life in youth with Type 2 diabetes: the TODAY clinical trial." Diabetes management (London, England) vol. 5,6 (2015): 431-439. doi: https://doi.org/10.2217/dmt.15.35
Larkin ME, Walders-Abramson N, Hirst K, Keady J, Ievers-Landis CE, Venditti EM, Yasuda PM. Effects of comorbid conditions on health-related quality of life in youth with Type 2 diabetes: the TODAY clinical trial. Diabetes Manag (Lond). 2015 Nov;5(6):431-439. doi: 10.2217/dmt.15.35. PMID: 27057209; PMCID: PMC4820314.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 14 entries